AB
Insider
Andrew S Boyer
Executive Vice PresidentAndrew S Boyer (Executive Vice President) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in Amneal Pharmaceuticals, Inc. (AMRX). The largest single filing was $2.6M of AMRX (279,244 sh × $9.38, as filed), executed Aug 20 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.0M
shares × price, as filed
Last traded
Aug 20 2025
Filed Aug 22 2025
Median ADV $37.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $4.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 24 months
Most traded names
AMRX
Amneal Pharmaceuticals, Inc.
AMRX · 0 buys · 3 sells
3 filings
Recent filings
AMRXSALE
Amneal Pharmaceuticals, Inc.
View filing →
$2.6M279,244 sh × $9.38
Exec Aug 20 2025
Filed Aug 22 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $303K
33,436 sh × $9.05
Exec Aug 12 2025
Filed Aug 13 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $1.1M
125,000 sh × $8.89
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET